Funding for Medical Researcher

US-based medical MR provider Verilogue has won a $4m investment from Edison Venture Fund. The proceeds will be used to expand development, marketing and sales.

Verilogue's patent-pending technology system captures real-time physician-patient conversations at the point-of-practice and enables physicians to digitally record conversations with select patients each month. The company's nationwide database of interactions provides feedback on specific medicines, competitive positioning and communication materials. Physician and patient information collected by Verilogue is made anonymous.

'The founders executed superbly and Verilogue is ramping quickly' comments John Martinson, Edison Managing Partner, who serves on the Board of Directors with Edison Director Network member Heather Torak, SVP Global Operations, Cadient. Orlando Mendoza, who along with Michael Cichowski conducted Edison's due diligence, said brand managers had 'raved about Verilogue's unique research techniques and insightful analysis.'

Verilogue CEO Jeff Kozloff says his firm was attracted to Edison, its sole institutional investor, by its 'category knowledge and success in supporting pharma information technology companies.'

Edison has funded and guided 14 pharma information technology companies. Established in 1986, it currently has $550 million under management and is actively making new investments. Web sites: www.edisonventure.com and www.verilogue.com.

All articles 2006-23 written and edited by Mel Crowther and/or Nick Thomas, 2024- by Nick Thomas, unless otherwise stated.